Biodesix, Inc. operates as a diagnostic solutions company. It engages in providing blood-based diagnostic tests and development services. The firm offers five diagnostic tests, including Nodify CDT, Nodify XL2, GeneStrat ddPCR, GeneStrat NGS, and VeriStrat. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.
Fundamentals
Mkt Cap
$308.09M
Volume
-
52W High
$31.31
52W Low
$5.26
PE Ratio
-9.21
Avg. Volume
135,016.04
EPS (Annual)
-$4.67
P/B
33.69
Rev/Employee
$264,967.07
Earnings
Nov 03
45
Neutral Sentiment
How do you feel about BDSX?
healthcareguru
$BDSX Despite this huge run, stock is still not overbought and is still DIRT CHEAP at 2.5x EV/sales vs comp group 4-6x…send her to $50!! 🦾🔥 $XLV $IWM $XBI